Literature DB >> 8406875

Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.

M R Wessels1, L C Paoletti, A K Rodewald, F Michon, J DiFabio, H J Jennings, D L Kasper.   

Abstract

Antisera elicited by type Ia group B streptococci (GBS) contain antibodies that react with both type Ia and type Ib strains. Previous studies suggested that antibodies elicited by type Ia organisms recognized a carbohydrate antigen or epitope common to Ia and Ib strains. We now report the synthesis and immunogenicity testing of a type Ia polysaccharide-tetanus toxoid (Ia-TT) conjugate vaccine. Ia-TT elicited type Ia polysaccharide-specific immunoglobulin G antibodies in all three of the rabbits inoculated. In competitive enzyme-linked immunosorbent assay, these antibodies reacted with high affinity to type Ia polysaccharide and with lower affinity to the structurally related GBS type Ib polysaccharide. Despite the lower binding affinity of the Ia-TT-induced antibodies for the type Ib polysaccharide, Ia-TT antiserum opsonized not only type Ia GBS but also type Ib GBS for killing by human blood leukocytes. Ia-TT antiserum was also evaluated in a mouse model designed to test the efficacy of maternal antibodies in protecting neonates against GBS infection. Pups born to dams that had received Ia-TT antiserum were protected against lethal challenge with either type Ia or Ib GBS. These studies using a polysaccharide-protein conjugate as an immunogen support the view that the carbohydrate immunodeterminant recognized on Ib strains by Ia antisera is a common epitope contained within the structurally related Ia and Ib capsular polysaccharides. Although antibodies elicited by Ia-TT had protective activity against both Ia and Ib strains, these antibodies reacted with lower affinity to Ib than to Ia polysaccharide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406875      PMCID: PMC281231          DOI: 10.1128/iai.61.11.4760-4766.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Systems of materno-foetal transport of gamma G immunoglobulin in the mouse.

Authors:  D Gitlin; L G Morphis
Journal:  Nature       Date:  1969-07-12       Impact factor: 49.962

Review 3.  Group B streptococcal infections.

Authors:  C J Baker
Journal:  Adv Intern Med       Date:  1980

4.  Transplacental passage of IgG antibody to group B streptococcus serotype Ia.

Authors:  K M Boyer; C K Papierniak; C A Gadzala; J D Parvin; S P Gotoff
Journal:  J Pediatr       Date:  1984-04       Impact factor: 4.406

5.  Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus.

Authors:  H J Jennings; E Katzenellenbogen; C Lugowski; D L Kasper
Journal:  Biochemistry       Date:  1983-03-01       Impact factor: 3.162

6.  Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

Authors:  C J Baker; M S Edwards; B J Webb; D L Kasper
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

Review 7.  Review article: Fc gamma receptors in the human placenta.

Authors:  P M Johnson; P J Brown
Journal:  Placenta       Date:  1981 Oct-Dec       Impact factor: 3.481

8.  ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.

Authors:  B M Gray
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

Review 9.  Group B streptococcal vaccines.

Authors:  C J Baker; D L Kasper
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

10.  Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.

Authors:  H J Jennings; C Lugowski
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

View more
  46 in total

1.  Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.

Authors:  Ximei Sun; Giuseppe Stefanetti; Francesco Berti; Dennis L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

2.  The changing face of childhood meningitis.

Authors:  D Scheifele
Journal:  Can J Infect Dis       Date:  1994-03

3.  Localization of surface immunogenic protein on group B streptococcus.

Authors:  S Rioux; D Martin; H W Ackermann; J Dumont; J Hamel; B R Brodeur
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development.

Authors:  Isabella Santi; Renata Grifantini; Sheng-Mei Jiang; Cecilia Brettoni; Guido Grandi; Michael R Wessels; Marco Soriani
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

5.  Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.

Authors:  B R Brodeur; M Boyer; I Charlebois; J Hamel; F Couture; C R Rioux; D Martin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract.

Authors:  Tamsin R Sheen; Alyssa Jimenez; Nai-Yu Wang; Anirban Banerjee; Nina M van Sorge; Kelly S Doran
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

7.  Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  L C Paoletti; M R Wessels; A K Rodewald; A A Shroff; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity.

Authors:  Sheng-Mei Jiang; Nadeeza Ishmael; Julie Dunning Hotopp; Manuela Puliti; Luciana Tissi; Nikhil Kumar; Michael J Cieslewicz; Hervé Tettelin; Michael R Wessels
Journal:  J Bacteriol       Date:  2008-01-18       Impact factor: 3.490

9.  Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus.

Authors:  Cira Daniela Rinaudo; Roberto Rosini; Cesira L Galeotti; Francesco Berti; Francesca Necchi; Valerio Reguzzi; Claudia Ghezzo; John Laird Telford; Guido Grandi; Domenico Maione
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

10.  Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor.

Authors:  A Podbielski; O Blankenstein; R Lütticken
Journal:  Med Microbiol Immunol       Date:  1994-11       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.